Enterprise Value (EV)
Paying user area
Try for free
Biogen Inc. pages available for free this week:
- Income Statement
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Biogen Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Biogen Inc., current enterprise value calculation
| Current share price (P) | |
| No. shares of common stock outstanding | |
| US$ in thousands | |
| Common equity (market value)1 | |
| Add: Preferred stock, par value $0.001 per share (per books) | |
| Add: Noncontrolling interests (per books) | |
| Total equity | |
| Add: Current portion of notes payable (per books) | |
| Add: Notes payable, excluding current portion (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Marketable securities | |
| Enterprise value (EV) | |
Based on: 10-K (reporting date: 2021-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Biogen Inc., EV calculation
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Biogen Inc. Annual Report.
3 2021 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
- Common Equity (Market Value)
- There is a consistent downward trend observed in the common equity market value over the five-year period. The value decreased from approximately 73.2 billion US dollars in 2017 to around 32.4 billion US dollars by the end of 2021, reflecting a significant decline of more than 55%. This steady decrease indicates a reduction in market valuation of the company's common equity.
- Total Equity
- Total equity follows a very similar declining pattern as common equity, starting at approximately 73.2 billion US dollars in 2017 and dropping to approximately 32.4 billion US dollars by 2021. The close alignment between total equity and common equity values throughout the years suggests limited issuance of preferred shares or other components of equity beyond common stock.
- Total Equity and Debt
- The combined total of equity and debt also shows a marked downward trend, decreasing from approximately 79.1 billion US dollars in 2017 to around 39.7 billion US dollars in 2021. This indicates a contraction in the overall capital base of the company, implying either a reduction in debt levels, equity, or both. The rate of decline in total equity and debt is slightly less steep than the decline observed in total equity alone, suggesting some offsetting effect from debt variations.
- Enterprise Value (EV)
- The enterprise value exhibits a decreasing trajectory from about 75.4 billion US dollars in 2017 to roughly 35.9 billion US dollars by the end of 2021. This decline mirrors the decrease in total equity and total capital, indicating a diminishing overall valuation of the business, factoring in equity and debt components. The pattern shows the company's enterprise value nearly halved over the period analyzed, consistent with the reductions in equity and total capitalization.